Evaluation of antioxidant effects of antiepileptic drugs in adult epileptic patients
- Conditions
- Health Condition 1: null- EPILEPSY PATIENTS
- Registration Number
- CTRI/2017/12/010840
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 39
Newly diagnosed drug naive epileptic patients aged between 18-60 years of age of either gender
Patients who will be initiated on monotherapy with phenytoin or levetiracetam or oxcarbazepine
Patients who are willing to give informed consent
Patients with history of psychiatric or progressive neurological disorders
Patients with history of other co morbid conditions like ischemic heart disease kidney disease liver disease thyroid disorders and other endocrinopathies
Patients with history of diseases that could influence the level of oxidative stress such as diabetes mellitus arterial hypertension malignancies recent surgery and trauma
Patients on drugs that influence the level of oxidative stress such as vitamins herbal medicines for the last 3 months
Pregnant and lactating women
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method